Skip to main content

Autologous Tumor Cells Modified to Exhibit alpha-Gal Antigens as Anti-Cancer Vaccines (Resubmission)

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 4, 2013
Award amount: 
Organization name: 
East Carolina University
Principal Investigator: 
Wiley, John E.
Grant program category: 
Research and Equipment Support
Grant program name: 
Biotechnology Research Grant

This research investigates ways to change tumor cells from patients so that they show a foreign, non-human molecule called alphaGal on their surface. This surface molecule will enable the tumor cells to be detected and destroyed by the patient's own immune responses as a new type of cancer immunotherapy.

Fiscal year: